Hypermarcas (OTCMKTS:HYPMY) Stock Price Down 4% – What’s Next?

Hypermarcas (OTCMKTS:HYPMY) shares were down 4% during mid-day trading on Monday . The stock traded as low as $4.2250 and last traded at $4.2250. Approximately 1,270 shares changed hands during trading, a decline of 98% from the average daily volume of 51,829 shares. The stock had previously closed at $4.40.

Hypermarcas Price Performance

The company has a market cap of $2.79 billion, a P/E ratio of 17.96 and a beta of 0.73. The stock has a 50-day simple moving average of $4.53 and a 200 day simple moving average of $4.51. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27.

Hypermarcas (OTCMKTS:HYPMY) last issued its earnings results on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. The business had revenue of $408.83 million during the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.